Background & Aims HCV reinfection following successful treatment can compromise
treatment outcomes. This systematic review assessed the rate of HCV reinfection following …

Hepatitis C virus (HCV) is a global health problem, because infection frequently leads to
chronic hepatitis C eventually progressing to liver cirrhosis and liver cancer. Improved …

HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

The treatment of hepatitis C has become safer, better tolerated and more effective owing to
the availability of direct-acting antivirals for nearly all patients; this guideline advocates …

Background The benefits of direct-acting antivirals towards the elimination of hepatitis C
virus (HCV) in people living with HIV are decreased when individuals are reinfected with …

Hepatitis C virus (HCV) infection is the major risk factor for liver cirrhosis and hepatocellular
carcinoma (HCC). The mechanisms of HCC initiation, growth, and metastasis appear to be …

ABSTRACT Background & Aims Scale-up of highly-effective direct-acting antivirals (DAAs)
for hepatitis C virus (HCV) among people who inject drugs (PWID) in Scotland has led to a …

Hepatitis C virus (HCV) infection remains a major public health issue with high prevalence in
Taiwan. Recently, the advent of direct-acting antiviral (DAA) agents, with higher efficacy …

Answer questions and earn CME/CNE Chronic hepatitis C virus (HCV) infection affects
millions of people worldwide and is associated with cancer. Direct‐acting antivirals (DAAs) …